Staging algorithm for diffuse malignant pleural mesothelioma

Interactive Cardiovascular and Thoracic Surgery

Volumn 10, Issue 2, 2010, Pages 185-189

  Zieliński, Marcin ^a   Hauer, Jolanta ^a   Hauer, Lukasz ^a   Pankowski, Juliusz ^a   Nabialek, Tomasz ^a   Szlubowski, Artur ^a  

^a PULMONARY HOSPITAL   (Poland)

Author keywords

Malignant mesothelioma; Pleura; Staging

Indexed keywords

TALC;

ADULT; AGED; ALGORITHM; CANCER CELL; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; ECHOGRAPHY; ENDOBRONCHIAL ENDOESOPHAGEAL ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LAPAROSCOPY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MALIGNANT MESOTHELIOMA; MEDIASTINUM LYMPH NODE; METASTASIS; PERITONEUM LAVAGE; PLEURA BIOPSY; PLEURA FLUID; PLEURA MESOTHELIOMA; PLEURODESIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THORACOSCOPY; THORACOTOMY; THORAX WALL; TRANSCERVICAL EXTENDED MEDIASTINAL LYMPHADENECTOMY;

ADULT; AGED; ALGORITHMS; BIOPSY; CHEMOTHERAPY, ADJUVANT; ENDOSONOGRAPHY; FEMALE; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MEDICAL FUTILITY; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; PERITONEAL LAVAGE; PLEURAL NEOPLASMS; PLEURODESIS; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY, ADJUVANT; THORACOSCOPY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 75449084024     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.213611     Document Type: Conference Paper

References (15)

1. Paul S, Neragi-Miandoab S, Jaklitsch MT. Preoperative assessment and therapeutic options for patients with malignant pleural mesothelioma. Thorac Surg Clin 2004;14:505-516.
2. Metinas M, Ak G, Erginel S, Alatas F, Yildrim H, Kurt E, Metinas S. A retrospective analysis of malignant pleural mesothelioma patients treated either with chemotherapy or best supportive care between 1990 and 2005. A single institution experience. Lung Cancer 2007;55: 379-387.
3. Sugarbaker DJ, Garcia JP, Richards WG, Harpole DH Jr, Baldini HE, DeCamp MM Jr, Mentzer SJ, Liptay MJ, Strauss GM, Swanson SJ. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg 1996;224:288-294.
4. Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 1995;108:1122-1128.
5. Szlubowski A, Kuzdzał J, Kołodziej M, Soja J, Pankowski J, Obrochta A, Kopiński P, Zieliński M. Endobronchial ultrasound-guided needle aspiration in the non-small cell lung cancer staging. Eur J Cardiothorac Surg 2009;35:332-336.
6. Tournoy KG, Burgers SA, Annema JT, Vermassen F, Praet M, Smits M, Klomp HM, van Meerbeeck JP, Baas P. Transesophageal endoscopic ultrasound with fine needle aspiration in the preoperative staging of malignant pleural mesothelioma. Clin Cancer Res 2008;14:6259-6263.
7. Kuzdzal J, Zieliński M, Papla B, Szlubowski A, Hauer Ł, Nabiałlek T, Sośnicki W, Pankowski J. Transcervical extender mediastinal lymphadenectomy - the new operative technique and early results in lung cancer staging. Eur J Cardiothorac Surg 2005;27:384-390.
8. Sagarbaker DJ, Flores RM, Jaklitsch M, Richards WG, Strauss GM, Corson JM, DeCamp MM, Swanson SJ, Bueno R, Lukanich JM, Baldini EH, Mentzer SJ. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-65.
9. Bueno R, Reblando J, Glickman J, Jaklitsch MT, Lukanich J, Sugarbaker DJ. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg 2004;78:1774-1776.
10. Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WR. Extended surgical staging for potentially respectable malignant pleural mesothelioma. Ann Thorac Surg 2005;80:1988-1993.
11. Edwards J, Stewart DJ, Martin-Ucar A, Muller S, Richards C, Waller D. The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma. J Thorac Cardiovasc Surg 2006;131:981-987.
12. de Perrot M, Uy K, Anraku M, Tsao MS, Darling G, Waddell TK, Pierre AF, Bezjak A, Keshavjee S, Johnston MR. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2007;133:111-116.
13. Sorensen JB, Ravn J, Loft A, Brenoe J, Berthelsen AK. Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomographyyCT fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy. Eur J Cardiothorac Surg 2008;34:1090-1096.
14. Schouwink JH, Kool LS, Rutgers EJ, Zoetmulder FA, Van Zandwijk N, Vijver MJ, Baas P. The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma. Ann Thorac Surg 2003;75:1715-1719.
15. Erasmus JJ, Truong MT, Smythe WR, Munden RF, Marom EM, Rice DC, Vaporciyan AA, Walsh GL, Sabloff, Broemeling LD, Stevens CW, Pisters KM, Podoloff DA, Macapinlac HA. Integrated computed tomography-positron emission tomography in patients with potentially respectable malignant pleural mesothelioma: staging implications. J Thorac Cardiovasc Surg 2005;129:1364-1370.